Beyond BMI: insulin resistance emerges as the key metabolic correlate of AMH in PCOS - Summary - MDSpire

Beyond BMI: insulin resistance emerges as the key metabolic correlate of AMH in PCOS

  • By

  • Amalia Gorzko

  • Jolanta Nawrocka-Rutkowska

  • Edyta Śliwak

  • Andrzej Starczewski

  • Iwona Szydłowska

  • July 9, 2026

  • 0 min

Share

Objective:

To determine the relationship between AMH levels and metabolic parameters among reproductive-age women with PCOS in Poland.

Approach:
  • Study Design: Retrospective study involving 156 women with PCOS and 156 controls without PCOS.
  • Measurements: Serum AMH, fasting glucose, and fasting insulin concentrations were measured; insulin resistance assessed using HOMA-IR.
  • Statistical Analysis: Multiple regression, interaction, and mediation analyses were performed to evaluate relationships between BMI, insulin resistance, and AMH levels.
Key Findings:
  • A negative association between AMH concentration and both fasting insulin and HOMA-IR was found.
  • The relationship between HOMA-IR and AMH is independent of BMI.
  • The association between BMI and AMH is weaker and mediated by insulin resistance.
Interpretation:

Insulin resistance is a stronger metabolic correlate of AMH levels than BMI in women with PCOS.

Limitations:
  • The study is retrospective and may be subject to selection bias.
  • Participants were from a specific geographic region, limiting generalizability.
Conclusion:

Metabolic dysfunction is associated with AMH alterations in PCOS.

Original Source(s)

Related Content